Amy L Winship
Overview
Explore the profile of Amy L Winship including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winship A, Alesi L, Stringer J, Cao Y, Lewis Y, Tu L, et al.
EBioMedicine
. 2024 Jul;
106:105262.
PMID: 39084071
Background: An estimated 1 in 350 women carry germline BRCA1/2 mutations, which confer an increased risk of developing breast and ovarian cancer, and may also contribute to subfertility. All mature,...
2.
Massarotti C, Ammar O, Liperis G, Mincheva M, Fraire-Zamora J, Sharma K, et al.
Hum Reprod
. 2024 Apr;
39(6):1357-1361.
PMID: 38593422
No abstract available.
3.
Menkhorst E, Santos L, Zhou W, Yang G, Winship A, Rainczuk K, et al.
Front Immunol
. 2023 Jun;
14:1175926.
PMID: 37292200
Introduction: Preeclampsia is a life-threatening disorder of pregnancy unique to humans. Interleukin (IL)11 is elevated in serum from pregnancies that subsequently develop early-onset preeclampsia and pharmacological elevation of IL11 in...
4.
Griffiths M, Higgins J, Cousins F, Alesi L, Winship A, Hutt K
J Vis Exp
. 2023 Apr;
(194).
PMID: 37092827
For pregnancy to be established, a viable blastocyst must successfully interact with a receptive uterine lining (endometrium) to facilitate implantation and placenta formation and enable ongoing pregnancy. The limitations to...
5.
Alesi L, Nguyen Q, Stringer J, Winship A, Hutt K
Reprod Fertil
. 2023 Apr;
PMID: 37068157
Cytotoxic chemotherapies have been a mainstay of cancer treatment, but are associated with numerous systemic adverse effects, including impacts to fertility and endocrine health. Irreversible ovarian damage and follicle depletion...
6.
Griffiths M, Marshall S, Cousins F, Alesi L, Higgins J, Giridharan S, et al.
JCI Insight
. 2023 Mar;
8(6).
PMID: 36946464
Female cancer survivors are significantly more likely to experience infertility than the general population. It is well established that chemotherapy and radiotherapy can damage the ovary and compromise fertility, yet...
7.
Stringer J, Alesi L, Winship A, Hutt K
Hum Reprod Update
. 2023 Mar;
29(4):434-456.
PMID: 36857094
Background: Regulated cell death is a fundamental component of numerous physiological processes; spanning from organogenesis in utero, to normal cell turnover during adulthood, as well as the elimination of infected...
8.
Giridharan S, Hutt K, Winship A
Reproduction
. 2022 Oct;
164(6):V15-V18.
PMID: 36215096
Human genome-wide association studies and evidence from animal models link ovarian ageing to double-strand (ds)DNA break repair capacity. Is there a connection between single-strand (ss)DNA repair mechanisms and ovarian function?...
9.
Targhazeh N, Hutt K, Winship A, Reiter R, Yousefi B
Biochimie
. 2022 Sep;
202:71-84.
PMID: 36116742
Multi drug resistance (MDR) generally limits the efficacy of chemotherapy in cancer patients and can be categorized into primary or acquired resistance. Melatonin (MLT), a lipophilic hormone released from pineal...
10.
Winship A, Alesi L, Sant S, Stringer J, Cantavenera A, Hegarty T, et al.
Nat Cancer
. 2022 Aug;
3(8):1-13.
PMID: 36008687
Loss of fertility is a major concern for female reproductive-age cancer survivors, since a common side-effect of conventional cytotoxic cancer therapies is permanent damage to the ovary. While immunotherapies are...